Gail Rodgers received her Doctorate in Medicine from Temple University School of Medicine. She did her pediatric residency and pediatric infectious diseases fellowship at St. Christopher’s Hospital for Children in Philadelphia where she served as attending physician and Associate Professor for nine years. In 2005 she moved to industry worked as Senior Director for Vaccines Scientific Affairs at Wyeth and Pfizer, where she led the strategy to incorporate pneumococcal conjugate vaccine in emerging markets. She led a multinational population-based epidemiologic study to assess the burden of pneumonia and invasive pneumococcal disease in Latin America. Additionally, she evaluated the global epidemiology of S. aureus and C. difficile to anticipate global need and usage of potential vaccines for these diseases. Prior to joining BMGF, worked as an independent consultant working to promote vaccine usage in Latin America and Asia. Since joining the Pneumonia Team at the Bill & Melinda Gates Foundation in October 2014, she has led the Pneumococcus Initiative with a focus on development of a low cost pneumococcal vaccine, assessment of alternate dosing strategies of pneumococcal conjugate vaccine (PCV), and assessment of impact of PCVs in GAVI Alliance countries. Gail also leads the Meningococcal Initiative that focuses on the development and use of meningococcal vaccines to decrease the burden of meningitis globally and especially in the African meningitis belt. Additionally, she lead the effort to understand the role of household air pollution (HAP) on pneumonia in children and interventions that can be done to decrease pneumonia due to HAP.